for immediate release
April 14, 2025 07:00 a.m. Pacific Standard Time
TUCSON A.Z. – UGenome AI, a pioneer in genomic platforms to fuel personalized medicine, today announced a deal with Credtent to use Credtent’s Certified Human-Composed Creation origin badge on UGenome-produced scientific content. Displaying the badge of human written authenticity offers a crucial step forward in transparent, ethical content practices in an era of generative AI.
“Accuracy of healthcare data impacts lives, making tools that identify what is AI generated versus human written essential. Scientific genomic research cannot take a risk with unsupervised generative AI responses and content,” said Eric Burgess, CEO of Credtent. “Credtent is working with UGenome as a neutral third-party utility to help consumers verify UGenome’s commitment to ensuring a human response and explanation with any published scientific content.”
Peer-reviewed scientific journals, such as Nature, currently do not allow submission of articles written by Large Language Models (LLMs), such as ChatGPT1,2. Such regulations often apply to both content submitted for publication as well as to limitations on allowing these language models to peer review articles. With such restrictions in place, companies and consumers can benefit from trusted ways to distinguish what is human-written versus authored by AI.
Credtent’s Human-Composed Creation badge supports in this endeavor as any content baring the badge runs through the platform’s multitool analysis, including human editorial review, to certify its authenticity as not written by AI. This added layer of independent certification helps companies stand out to consumers who value authenticity in their media consumption.
“We’re excited to partner with Credtent so our clients and collaborators can continue to trust UGenome content to fuel their research, knowing everything published is human-written,” said Zachary Brooks, PhD, founder and CEO of UGenome AI. “We look forward to this collaboration and continuing to empower our partners with trusted sources of information for pharmacogenomic content, analysis, and insights.”
About UGenome AI
UGenome AI is a startup biotech company focusing on developing genomics software. UGenome AI is advancing genomics analysis and helping patients receive personalized care, faster. Our products stem from our personalized reference genome and pharmacogenomics tools to help patients receive personalized treatments within weeks, not years. For more information, please visit www.ugenome.bio.
Contacts
For UGenome AI Inquiries:
Zachary Brooks
[email protected]
For Media:
Emma Bardin
References